Chenghao Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chenghao Guo has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Changtao Jiang
Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing, China
3 shared publications - Jie Qiao
State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China
2 shared publications - Kai Wang
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P. R. China
2 shared publications - Meng Li
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China
2 shared publications - Yanli Pang
State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital Key Laboratory of Assisted Reproduction, Peking University, Ministry of Education Beijing Key Laboratory of Collaborative Innovation in Frontier Technologies for Population Quality Beijing China
2 shared publications Bangjian Dong
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China
1 shared publication
Latest Publications
- 5 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 394 (6824)
Targeting hormone conversion through dietary fiber improves polyendocrine metabolic ovarian syndrome
Excessive androgens serve as a primary driver for many phenotypic features of polyendocrine metabolic ovarian syndrome (PMOS). Although dietary fiber has been shown to alleviate PMOS, its effects on androgen concentrations and the underlying mechanisms remain unclear. In a clinical trial, we demonstrated that a dietary fiber combination consisting of inulin, resistant starch, and β-glucan reduces androgen concentrations in patients’ plasma. Mechanistically, dietary fiber increased the abundance of Bacteroides xylanisolven s, which converts androstenedione into a nonandrogenic secondary hormone metabolite we named coproandrosterone, which is further metabolized by gut microbiota into dihydro-coproandrosterone. This metabolic pathway was validated in a mouse model. These findings highlight the potential of dietary fiber to alleviate PMOS by modulating androgen homeostasis through gut microbiota, offering insights for prebiotic and probiotic therapies.
- 5 November 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 394 (6824)
Targeting hormone conversion through dietary fiber improves polyendocrine metabolic ovarian syndrome
Excessive androgens serve as a primary driver for many phenotypic features of polyendocrine metabolic ovarian syndrome (PMOS). Although dietary fiber has been shown to alleviate PMOS, its effects on androgen concentrations and the underlying mechanisms remain unclear. In a clinical trial, we demonstrated that a dietary fiber combination consisting of inulin, resistant starch, and β-glucan reduces androgen concentrations in patients’ plasma. Mechanistically, dietary fiber increased the abundance of Bacteroides xylanisolven s, which converts androstenedione into a nonandrogenic secondary hormone metabolite we named coproandrosterone, which is further metabolized by gut microbiota into dihydro-coproandrosterone. This metabolic pathway was validated in a mouse model. These findings highlight the potential of dietary fiber to alleviate PMOS by modulating androgen homeostasis through gut microbiota, offering insights for prebiotic and probiotic therapies.
- 3 November 2026
- Published by Elsevier in Cell Metabolism
- Vol. 38 (11) , 2165-2166
Metformin-supportive nutrition: When gut microbes eat drugs
- 3 November 2026
- Published by Elsevier in Cell Metabolism
- Vol. 38 (11) , 2165-2166
Metformin-supportive nutrition: When gut microbes eat drugs
- Top Cited Papers
- 1 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6746) , eadp5540
A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite–CerS6–ceramide axis
The gut microbiota is known to be associated with a variety of human metabolic diseases, including metabolic dysfunction–associated steatohepatitis (MASH). Fungi are increasingly recognized as important members of this community; however, the role of fungal symbionts in metabolic diseases is unknown. We have systematically isolated and characterized gut fungi, identifying Fusarium foetens as an intestinal symbiotic filamentous fungus in mice. F. foetens reverses MASH progression in mouse models through an intestinal ceramide synthetase 6 (CerS6)–ceramide axis. Moreover, we identified FF-C1, a secondary metabolite from F. foetens , as a CerS6 inhibitor that has an endogenous protective effect on MASH progression.
- 1 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6746) , eadp5540
Top Cited PapersA symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite–CerS6–ceramide axis
The gut microbiota is known to be associated with a variety of human metabolic diseases, including metabolic dysfunction–associated steatohepatitis (MASH). Fungi are increasingly recognized as important members of this community; however, the role of fungal symbionts in metabolic diseases is unknown. We have systematically isolated and characterized gut fungi, identifying Fusarium foetens as an intestinal symbiotic filamentous fungus in mice. F. foetens reverses MASH progression in mouse models through an intestinal ceramide synthetase 6 (CerS6)–ceramide axis. Moreover, we identified FF-C1, a secondary metabolite from F. foetens , as a CerS6 inhibitor that has an endogenous protective effect on MASH progression.